[HTML][HTML] Indwelling catheters for the management of refractory malignant ascites: a systematic literature overview and retrospective chart review

ND Fleming, A Alvarez-Secord… - Journal of pain and …, 2009 - Elsevier
The safety and efficacy of indwelling intraperitoneal (IP) catheters for the management of
refractory malignant ascites is unclear. A systematic literature overview and retrospective …

[HTML][HTML] Emerging trends in neoadjuvant chemotherapy for ovarian cancer

A Patel, P Iyer, S Matsuzaki, K Matsuo, AK Sood… - Cancers, 2021 - mdpi.com
Simple Summary Epithelial ovarian cancer is one of the most lethal cancers in women and is
typically diagnosed at an advanced-stage. Historically, primary tumor reductive surgery was …

Neoadjuvant pembrolizumab in localized microsatellite instability high/deficient mismatch repair solid tumors

K Ludford, WJ Ho, JV Thomas… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE Pembrolizumab significantly improves clinical outcomes in advanced/metastatic
microsatellite instability high (MSI-H)/deficient mismatch repair (dMMR) solid tumors but is …

A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer

PT Soliman, SN Westin, S Dioun, CC Sun… - Gynecologic …, 2017 - Elsevier
Objective Sentinel lymph node (SLN) mapping continues to evolve in the surgical staging of
endometrial cancer (EC). The purpose of this trial was to identify the sensitivity, false …

A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer

AA Secord, LJ Havrilesky, DM O'Malley… - Gynecologic …, 2009 - Elsevier
OBJECTIVES: The appropriate sequencing of chemotherapy and radiation for the treatment
of advanced endometrial cancer has not yet been determined. We sought to evaluate the …

Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer

SN Westin, B Fellman, CC Sun, RR Broaddus… - American journal of …, 2021 - Elsevier
Background The incidence of complex atypical hyperplasia and early-stage endometrioid
endometrial cancer is increasing, in part owing to the epidemic of obesity, which is a risk …

[PDF][PDF] Molecular analysis of clinically defined subsets of high-grade serous ovarian cancer

S Lee, L Zhao, C Rojas, NW Bateman, H Yao, OD Lara… - Cell reports, 2020 - cell.com
The diversity and heterogeneity within high-grade serous ovarian cancer (HGSC), which is
the most lethal gynecologic malignancy, is not well understood. Here, we perform …

Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence

A Carroll, PT Ramirez, SN Westin, PT Soliman… - Gynecologic …, 2014 - Elsevier
Objectives Uterine adenosarcoma is a rare malignancy with little data on optimal
management. We aimed to clarify the impact of adjuvant therapy in patients with uterine …

Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer

ND Fleming, M Frumovitz, KM Schmeler… - Gynecologic …, 2015 - Elsevier
Objective The ratio of positive to negative lymph nodes, or lymph node ratio (LNR), is an
important prognostic factor in several solid tumors. The objective of this study was to …

Same-day discharge is feasible and safe in patients undergoing minimally invasive staging for gynecologic malignancies

KR Penner, ND Fleming, L Barlavi, AE Axtell… - American journal of …, 2015 - Elsevier
Objective The objective of the study was to evaluate the feasibility and safety of same-day
discharge of patients undergoing minimally invasive comprehensive surgical staging for …